Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Prcina

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Medical Hypotheses|February 1, 2011
Has prion protein important physiological function?Michal Prcina, Eva Kontsekova
Journal of Alzheimer'S Disease : JAD|June 23, 2011
Tauons and prions: infamous cousins?Petr Novak, Michal Prcina, Eva Kontsekova
Acta Neuropathologica Communications|May 31, 2020
Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammationMonika Zilkova, Anna Nolle, Branislav Kovacech, et al.
Alzheimer'S Research & Therapy|October 26, 2018
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's diseasePetr Novak, Reinhold Schmidt, Eva Kontsekova, et al.
The Lancet. Neurology|December 14, 2016
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trialPetr Novak, Reinhold Schmidt, Eva Kontsekova, et al.
Nature Aging|April 28, 2023
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's diseasePetr Novak, Branislav Kovacech, Stanislav Katina, et al.
Ebiomedicine|January 25, 2022
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concernBranislav Kovacech, Lubica Fialova, Peter Filipcik, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Medical Hypotheses|February 1, 2011
Has prion protein important physiological function?Michal Prcina, Eva Kontsekova
Journal of Alzheimer'S Disease : JAD|June 23, 2011
Tauons and prions: infamous cousins?Petr Novak, Michal Prcina, Eva Kontsekova
Acta Neuropathologica Communications|May 31, 2020
Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammationMonika Zilkova, Anna Nolle, Branislav Kovacech, et al.
Alzheimer'S Research & Therapy|October 26, 2018
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's diseasePetr Novak, Reinhold Schmidt, Eva Kontsekova, et al.
The Lancet. Neurology|December 14, 2016
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trialPetr Novak, Reinhold Schmidt, Eva Kontsekova, et al.
Nature Aging|April 28, 2023
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's diseasePetr Novak, Branislav Kovacech, Stanislav Katina, et al.
Ebiomedicine|January 25, 2022
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concernBranislav Kovacech, Lubica Fialova, Peter Filipcik, et al.
Pageof 1